Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Revlimid brand name?

See the DrugPatentWatch profile for Revlimid

What is Revlimid (brand name) and what is its generic name?

Revlimid is the brand name for lenalidomide, an oral medicine used to treat certain blood cancers and other conditions.

What is Revlimid used for?

Revlimid is used for treatment in specific settings involving blood cancers (for example, multiple myeloma and related disorders), depending on the approved indication and patient population.

Who makes Revlimid?

Revlimid is marketed by Bristol Myers Squibb (BMS).

Is there a generic version of Revlimid?

Because Revlimid is lenalidomide, lower-cost alternatives are generally discussed in terms of whether lenalidomide products (or “generic” versions, depending on approval and availability) are available in a given market. Patent and exclusivity status can affect when competitors launch; DrugPatentWatch.com tracks these kinds of timelines and related legal events.
Source: DrugPatentWatch.com – Revlimid (lenalidomide)

Why do people ask “Revlimid vs lenalidomide”?

Patients and clinicians often search this because the active ingredient is lenalidomide, so they want to know whether a different name (or product) is the same drug, and whether dosing, side-effect profile, and prescribing guidance match the branded product.



Other Questions About Revlimid :

difference between revlimid and pomalyst lenalidomide (revlimid) patent expiration date lenalidomide (revlimid) main patent expiration date lenalidomide (revlimid) market exclusivity status dec 2024 revlimid (lenalidomide) patent expiration date How does revlimid function as an immunomodulatory agent? What is the patent expiry for revlimid?